Viridian Therapeutics, Inc./DE

VRDN ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2018

Total Assets: $66.1M

Liabilities Breakdown FY2018

Total Liabilities: $14.8M